Clinical Trial Update: Cardiac Resynchronization Therapy (CRT)-Narrow-dp/Dt-Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the CRT-Narrow-dp/Dt study in heart failure; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Cardiac Resynchronization Therapy device

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure | Phase 4 | Status: COMPLETED